Semi-Annual Consolidated Statement Of Cash Flows

DAIKEN MEDICAL CO.,LTD - Filing #7303633

Concept 2024-04-01 to
2024-09-30
As at
2024-09-30
As at
2024-03-31
2023-04-01 to
2023-09-30
As at
2023-09-30
As at
2023-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
836,448,000 JPY
750,156,000 JPY
Depreciation
113,443,000 JPY
104,185,000 JPY
Interest and dividend income
0 JPY
0 JPY
Interest expenses
3,431,000 JPY
2,407,000 JPY
Decrease (increase) in trade receivables
-21,644,000 JPY
-53,463,000 JPY
Decrease (increase) in inventories
56,207,000 JPY
-63,245,000 JPY
Increase (decrease) in trade payables
-40,748,000 JPY
18,173,000 JPY
Other, net
-26,504,000 JPY
-42,339,000 JPY
Subtotal
709,967,000 JPY
802,293,000 JPY
Interest and dividends received
0 JPY
0 JPY
Interest paid
-4,193,000 JPY
-2,488,000 JPY
Income taxes paid
-232,297,000 JPY
-197,086,000 JPY
Net cash provided by (used in) operating activities
473,476,000 JPY
602,718,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-74,882,000 JPY
-110,958,000 JPY
Net cash provided by (used in) investing activities
-76,035,000 JPY
-110,942,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
750,000,000 JPY
JPY
Repayments of long-term borrowings
-219,986,000 JPY
-229,986,000 JPY
Dividends paid
-344,886,000 JPY
-315,557,000 JPY
Net cash provided by (used in) financing activities
20,189,000 JPY
-350,481,000 JPY
Net increase (decrease) in cash and cash equivalents
417,631,000 JPY
141,294,000 JPY
Cash and cash equivalents
3,156,773,000 JPY
2,739,141,000 JPY
2,657,507,000 JPY
2,516,212,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.